These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 28537465

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In vitro evaluation of archaeosome vehicles for transdermal vaccine delivery.
    Jia Y, McCluskie MJ, Zhang D, Monette R, Iqbal U, Moreno M, Sauvageau J, Williams D, Deschatelets L, Jakubek ZJ, Krishnan L.
    J Liposome Res; 2018 Dec; 28(4):305-314. PubMed ID: 28948854
    [Abstract] [Full Text] [Related]

  • 6. Mechanistic insight into the induction of cellular immune responses by encapsulated and admixed archaeosome-based vaccine formulations.
    Agbayani G, Jia Y, Akache B, Chandan V, Iqbal U, Stark FC, Deschatelets L, Lam E, Hemraz UD, Régnier S, Krishnan L, McCluskie MJ.
    Hum Vaccin Immunother; 2020 Sep 01; 16(9):2183-2195. PubMed ID: 32755430
    [Abstract] [Full Text] [Related]

  • 7. Sulfated lactosyl archaeol (SLA) archaeosomes as a vaccine adjuvant.
    Akache B, McCluskie MJ.
    Hum Vaccin Immunother; 2024 Dec 31; 20(1):2395081. PubMed ID: 39278862
    [Abstract] [Full Text] [Related]

  • 8. Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum.
    Krishnan L, Dicaire CJ, Patel GB, Sprott GD.
    Infect Immun; 2000 Jan 31; 68(1):54-63. PubMed ID: 10603368
    [Abstract] [Full Text] [Related]

  • 9. A comparison of the immune responses induced by antigens in three different archaeosome-based vaccine formulations.
    Jia Y, Akache B, Deschatelets L, Qian H, Dudani R, Harrison BA, Stark FC, Chandan V, Jamshidi MP, Krishnan L, McCluskie MJ.
    Int J Pharm; 2019 Apr 20; 561():187-196. PubMed ID: 30836154
    [Abstract] [Full Text] [Related]

  • 10. Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems.
    Patel GB, Sprott GD.
    Crit Rev Biotechnol; 1999 Apr 20; 19(4):317-57. PubMed ID: 10723627
    [Abstract] [Full Text] [Related]

  • 11. Archaeosome immunostimulatory vaccine delivery system.
    Patel GB, Chen W.
    Curr Drug Deliv; 2005 Oct 20; 2(4):407-21. PubMed ID: 16305444
    [Abstract] [Full Text] [Related]

  • 12. Generation of a Liposomal Vaccine Adjuvant Based on Sulfated S-Lactosylarchaeol (SLA) Glycolipids.
    Akache B, Jia Y, Chandan V, Deschatelets L, McCluskie MJ.
    Methods Mol Biol; 2022 Oct 20; 2412():255-267. PubMed ID: 34918249
    [Abstract] [Full Text] [Related]

  • 13. Archaeosome adjuvants: immunological capabilities and mechanism(s) of action.
    Krishnan L, Sprott GD.
    Vaccine; 2008 Apr 16; 26(17):2043-55. PubMed ID: 18343538
    [Abstract] [Full Text] [Related]

  • 14. Safety of archaeosome adjuvants evaluated in a mouse model.
    Patel GB, Omri A, Deschatelets L, Sprott GD.
    J Liposome Res; 2002 Nov 16; 12(4):353-72. PubMed ID: 12519630
    [Abstract] [Full Text] [Related]

  • 15. Archaeosomes as self-adjuvanting delivery systems for cancer vaccines.
    Krishnan L, Dennis Sprott G, Institute for Biological Sciences, National Research Council of Canada.
    J Drug Target; 2003 Nov 16; 11(8-10):515-24. PubMed ID: 15203920
    [Abstract] [Full Text] [Related]

  • 16. New generation of liposomes called archaeosomes based on natural or synthetic archaeal lipids as innovative formulations for drug delivery.
    Benvegnu T, Lemiègre L, Cammas-Marion S.
    Recent Pat Drug Deliv Formul; 2009 Nov 16; 3(3):206-20. PubMed ID: 19534669
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sulfated Lactosyl Archaeol Archaeosomes Synergize with Poly(I:C) to Enhance the Immunogenicity and Efficacy of a Synthetic Long Peptide-Based Vaccine in a Melanoma Tumor Model.
    Akache B, Agbayani G, Stark FC, Jia Y, Dudani R, Harrison BA, Deschatelets L, Chandan V, Lam E, Hemraz UD, Régnier S, Krishnan L, McCluskie MJ.
    Pharmaceutics; 2021 Feb 12; 13(2):. PubMed ID: 33673382
    [Abstract] [Full Text] [Related]

  • 19. Simplified Admix Archaeal Glycolipid Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Enhances Protection from Murine Melanoma.
    Stark FC, Agbayani G, Sandhu JK, Akache B, McPherson C, Deschatelets L, Dudani R, Hewitt M, Jia Y, Krishnan L, McCluskie MJ.
    Biomedicines; 2019 Nov 23; 7(4):. PubMed ID: 31771150
    [Abstract] [Full Text] [Related]

  • 20. Archaeosomes varying in lipid composition differ in receptor-mediated endocytosis and differentially adjuvant immune responses to entrapped antigen.
    Sprott GD, Sad S, Fleming LP, Dicaire CJ, Patel GB, Krishnan L.
    Archaea; 2003 Oct 23; 1(3):151-64. PubMed ID: 15803661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.